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1. Introduction 
The increase in contractility which occurs in 
response to @-adrenergic stim~ation of the heart is 
thought to be mediated through changes in the levels 
of intracellular adenosine 3’,5’-cyclic monophosphate 
(cyclic AMP) [l-5] The possibility that guanosine 
3’S’-cyclic monophosphate (cyclic GNP) is also 
involved in regulating the contractile response of the 
heart has received comparatively little attention. This 
is somewhat surprising since it has been shown that 
the negative inotropic response to acetylcholine is 
associated with a rise in intracelfular cyclic GMP 
[6--81, and that the levels of both cyclic AMP and 
cyclic GMP undergo oscillatory changes which are 
synchronised with the cardiac cycle [9]. In addition, 
we demonstrated that the development of the hypo- 
dynamic condition [lo] and the inotropic response 
of the isolated frog ventricle to stimulation with 
exogenous ATP [ 11 ,121 are characterized by changes 
in the levels of both cyclic 3’,5’-nucleotides. Moreover, 
in each instance a striking correlation exists between 
changes in isometric twitch tension and the ratio of 
(cyclic AMP}/(cyclic GMP). 
This paper presents results which show changes in 
the levels of cyclic AMP and cyclic GMP following 
stimulation of the hypodynamic frog ventricle with 
the P-agonist isoprenaline and here too there is a clear 
correlation between the magnitude of the contractile 
response and the change in the cyclic nucleotide ratio. 
2. Methods 
Hearts from frogs, Rana ~ernp~ra~a and Rana 
esculenta, were isolated and superfused at room 
temperature (I&2O’C) by the method in [ 13 J . The 
perfusion rate was kept constant at 100 ml. min-* 
and the preparation was stimulated (Ag wire elec- 
trodes) at 30 min-’ (square, 5 ms pulses, 10 V). The 
ventricular strip was allowed to become hypodynamic 
and subsequently superfused with frog Ringer con- 
taining isoprenaline. At a predetermined time during 
the isoprenaline response it was freeze-clamped in 
liquid nitrogen. Another strip taken from the same 
ventricle was allowed to become hypodynamic to 
the same extent as the first and then freeze-clamped 
in liquid nitrogen. The latter served as the control 
strip. 
Frozen ventricular strips were pulverized into a 
powdered extract. Cyclic AMP and cyclic GMP from 
the latter were extracted and assayed by the techniques 
in [ 141 and [ 1.51, respectively. The amount of 
protein present in the extract was estimated by the 
method depicted by [ 161. Cyclic nucleotide results 
were expressed as pmol cyclic AMP or cyclic GMPfmg 
protein. 
3. Results and discussion 
Figure 1 shows the time course of the changes in 
intracellular cyclic AMP and cyclic GMP following 
superfusion of isolated frog (R. temporaria) ventric- 
ular strips with 10e6 M isoprenahne. The accom- 
panying contractile response is also shown (dashed 
line) for comparison. There are two points to empha- 
sise. First, the early increase in contractile force 
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Fig.1. Time courses of changes in contractile force (dashed 
Line) and intracellular levels of cyclic AMP (solid circles) and 
cyclic GMP (open circles) during exposure of the frog ventricle 
to 10e6 M isoprenaline. Control (hypodynamic) values 
(mean r SE) for cyclic AMP and cyclic GMP levels (pmol 
mg-’ . total protein) were 9.39 + 0.66 and 1.44 f 0.15, 
respectively (n = 17). 
corresponds more closely with an initial decrease in 
the level of cyclic GMP; the rise in the level of cyclic 
AMP is delayed and lags somewhat behind the con- 
tractile response. This result is of considerable interest 
since it was demonstrated in mamm~ian hearts 
[ 17-191 that a rise in cyclic AMP preceeds the 
onset of the inotropic response; indeed, this provides 
essential corroborative evidence in support of the 
‘second messenger’ ole for cyclic AMP [ 1 ] . Secondly, 
cyclic GMP levels reach to the control value (horizon- 
tal broken line) at about the time when the contractile 
response is maximal and further increase is accom- 
panied by a fall in isometric twitch tension and a 
decrease in the level of cyclic AMP. 
It was found earlier that a striking parallelism 
exists between the time course of the change in 
ventricular contractility and the ratio of the two cyclic 
nucleotides during both the development of the 
hypodynamic condition [lo] and during the inotropic 
response to exogenous ATP [ 121 . The results of tig.1. 
yield a similar correlation, as shown in fig.2A. This 
depicts the change in the ratio of cyclic AMP/cyclic 
GMP, that is: 
[ 
cyclic AMP/cyclic GMP (isop) 
-- __-_. 
cyclic AMP/cyclic GMP (hypo) I 
with time (solid triangles), together with the accom- 
panying tension response (open circles). Statistically, 
the correlation is highly significant (correlation 
Fig.2. A. Time course of the change in isometric twitch tension 
(open circtes) and cyclic nucleotide ratio (solid triangles) 
measured at various times during the response to loo6 M 
isoprenaline. Both parameters expressed as multiples of the 
control (hypodynamic) values. B. Data taken from fig.1. 
Cyclic nucleotide ratio plotted against contractile force. 
Solid line drawn with slope of 1. Correlation coefficient + SE 
of estimate: 0.995 + 0.143,n = 10,P < 0.001. 
coefficient rt SE of estimate: 0.995 +_ 0.143, n = 10, 
P < 0.001) and reveals a clear correspondence 
between a change in the cyclic nucleotide ratio and 
the accompanying change in force (fig.?iB, inset). 
The effects of altering the concentration of iso- 
prenaline on cyclic nucleotide levels and on contractile 
force for seven preparations is shown in tig.3,4. In 
2Ot.L 1 I I I I lJI.O 
lo-‘0 10-9 10-8 10-7 10-6 a5 to-’ 
Concentration of isoprenaline IMI 
Fig.3. Log dose-response curves for concentrations of iso- 
prenaline ranging from 10“’ -10e4 M. Solid circles, cyclic 
AIMP; open circles, cyclic GMP. Preparations superfused for 
approximately 100 s prior to freeze-clamping. Both param- 
eters expressed as multiples of control values. 
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Fig.4. A. Effects of isoprenaline ranging from 10-‘“-10-4 M 
on contractile force (open circles) and cyclic nucleotide ratio 
(solid triangles; data from fig.3). B. Relation between iso- 
metric force and cyclic nucleotide ratio (multiples of control 
values). Correlation coefficient + SE of estimate: 0.996 f 0.57, 
n = 7, P < 0.001. 
these experiments hearts from another species of frogs, 
R. ~sc~l~~l~a, were used. Figure 3 shows log dose- 
response curves for the increase in cyclic AMP (solid 
circles) and cyclic GMP (open circles) measured 
- 100 s after superfusing with the drug when the 
response was maximal. The change in the ratio of 
cyclic AMP/cyclic GMP with varying concentrations 
of isoprenaline and the corresponding change in 
isometric twitch tension, measured at the time of 
freeze-clamping each preparation, are shown in fig.4. 
The data again reveal a clear correlation (fig.4B. inset: 
correlation coefficient + SE of estimate: 0.996 t 0.057, 
n = 7, P < 0.00 1) between the cyclic nucleotide ratio 
and contractile force. 
These results, and those referred to earlier [ 10,121, 
lead us to postulate that cyclic AMP and cyclic GMP 
are important components of a control mechanism 
which regulates the capacity of the ventricle to 
produce force. The observed correlation between the 
ratio of the two cyclic nucleotides and isometric 
force suggests that they play opposing roles in the 
regulatory process, a feature which is seen in several 
other biological systems [20 ] . Both cyclic AMP and 
cyclic GMP are thought to exert their regulatory 
effects on cellular metabolism by activating a number 
of protein kinases, and several substrates for cyclic 
AMP-dependent protein kinases have been impticated 
in regulating myocardial contractility, troponin I 
(TN-I), a subunit of the regulatory protein complex 
[2 I] ; phospholamban, a 22 000 dalton protein con- 
stituent of the sarcoplasmic reticulum [22] ; and a 
surface membrane-bound protein, thought to be a 
component of the slow inward (calcium) current 
channel [23] . It has been previously demonstrated 
that perfusion of the rat hearts with isoprenaline 
produces a time-dependent increase in the state of 
phosphorylation of TN-I, which almost exactly paral- 
lels the time course of the resulting contractile 
response 1241. The existence of a similar relationship 
between the contractile force and the ratio cyclic 
AMP~cyclic GMP raises the possibility that the state 
of phosphorylation of TN-I and perhaps of other 
phosphoproteins involved in regulating force produc- 
tion may be determined by the relative amounts of 
intracellular cyclic AMP and cyclic GMP. A cyclic 
GMP-dependent protein kinase has been isolated 
from the heart [25], although to date there have 
been no reports of a naturally-occuring substrate for 
this enzyme in the heart. The phosphatase nzymes 
responsible for dephosphorylating protein substrates 
would appear to be plausible candidates in the light 
of the present results. 
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